Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers

Clinical trial NCT06963411 · COMPLETED

Trial details

NCT number: NCT06963411
Sponsor: Kokua Pharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Allergic Reaction Anaphylaxis

Start date: 2025-05-09
Primary completion: 2025-07-18
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.